Advertisement

Hyperbaric Oxygen in Diabetic Gangrene Treatment

  1. Giancarlo Baroni, MD,
  2. Tommaso Porro, MD,
  3. Ezio Faglia, MD,
  4. Gianluigi Pizzi, MD,
  5. Arturo Mastropasqua, MD,
  6. Giorgio Oriani, MD,
  7. Giorgio Pedesini, MD and
  8. Favales Favales, MD
  1. Center of Diabetology and Metabolic Diseases, Ospedale Niguarda Cà Granda Milan, Italy
  2. Service of Anesthesiology, Instituto Ortopedico Galeazzi Milan, Italy
  1. Send correspondence and reprint requests to Dr. Ezio Faglia, Via Monte Generoso, 50, 20155 Milan, Italy.

Abstract

We treated a group of 18 hospitalized adult diabetic patients (all with retinopathy, 17 with symptomatic neuropathy, and 6 with macroangiopathy) presenting with gangrenous lesions of the foot by a combined regime consisting of strict metabolic control, daily debridement of necrotic tissues, and daily hyperbaric oxygen (HBO) treatments given in a multiplace oxygen chamber. Another group of 10 adult subjects with comparable foot lesions (all with retinopathy, 9 with symptomatic neuropathy, and 4 with macroangiopathy) was treated in exactly the same way except for HBO. In the test treatment group, 16 patients were healed, and the remaining 2 showed no improvement and later underwent amputation.

The number of HBO treatments required for healing was significantly related to the size of gangrenous lesions. In the non-HBO-treated group, only 1 patient improved, 5 of 10 showed no change, and 4 of 10 worsened until leg amputation was unavoidable. Comparison of the two groups by X2-test revealed a highly significant difference (P = .001). In practical terms, HBO treatment drastically reduced leg amputations in patients so treated in the last 3 yr compared with earlier and current figures for patients not receiving HBO treatment.

| Table of Contents
Advertisement